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 Over the years, Electroanalysis has been widely applied to elucidate redox behavior of novel 
molecules. The selectivity and low cost are spotlight features in pharmacopeial methods of 
identification, that can be reached by voltammetric approaches. In this work, differential pulse 
voltammetric (DPV) profile and the slope of the linear regression obtained from calibration 
graphs along with the scan study are proposed as new perspective of identification assays. With 
the proposed methodology we were  able to identify the similarities among DPV profile and 
the slopes obtained for each tablet. In addition, this new technology was successfully employed 
to identify the following chemicals: Paracetamol (PAR), Promethazine (PMZ), Diclofenac 
(DIC), Piroxicam (PRX), Indomethacin (IND) and Cyclobenzaprine (CBP) in pharmaceutical 
assays using Pencil Graphite Electrodes. Furthermore, our new methodology was effectively 
compared to Raman Spectroscopy for the analysis of the range of chemicals in the 
pharmaceutical assays. 
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Introduction 
 
 
Routine laboratory drug analyses for quality control purposes are usually performed 
through classical, spectrophotometric and chromatographic methods [1]. These techniques 
often require strenuous pre-preparation of samples, costly equipment, organic solvents 
and/or time consuming procedures [2, 3]. In this context, electroanalysis has been shown 
to be an attractive alternative to evaluate of drugs because it presents advantages such as 
versatility, low cost, simplicity of application, among others. However, these techniques 
are limited by the low reproducibility, and there is a clear need to evaluate and propose the 
use of sensors that are easy to clean and that guarantee the recognized advantages of 
electroanalysis. Hence, the use of graphite pencil electrodes (GPE) has proven to be a 
useful and efficient and low cost tool for the determination of drugs in pharmaceutical 
formulations, without many of the drawbacks found in other methods [4-6].  
On the other hand, the electroanalytical studies have focused the quantitative drug 
analyses, yielding sensitivity in µmol L-1 ranges, whereas, there are only a few attempts in 
identification assays without the use of chemically modified electrodes (CME) [7-10]. 
Despite the employment of CMEs, voltammetry can display different analytical signals 
that distinguish species, that might be useful for identification purposes and deserves 
investigation [11].  
 
Among the instrumental methodologies mostly employed for identification 
purposes, we have the IV, Raman and NIR spectroscopies [12-15]. The benefits of non-
destructive and non-invasive sample analysis provided by Raman spectroscopy, are that 
reinforces its practical and direct application in pharmaceutical dosage forms without time 
consuming preparation steps [13, 14]. Meanwhile, though vibrational spectroscopic 
techniques offer significant singularity for each molecule, the direct use in dosage forms 
requires chemometrics approaches [13-15]. Indeed, the resulting “multi-peak” spectra are 
commonly, recognized as a fingerprint of a particular molecule, but this assumption is valid 
for drugs and excipients [13-15].  
 
Akin, many electroactive compounds can undergo a redox process at the same 
potential. In turn conforming electrochemical studies under controlled conditions, the 
relationship between electroactive compounds concentration and anodic peak is directly 
influenced by the diffusion coefficient and other unique physicochemical properties [16]. 
Indeed, for all species to reach the electrode surface to undergo redox reactions, there is a 
dependence of the overpotential that is closely related to the reaction speed of the analyte. 
The reaction rate, in turn, is influenced by unique molecular characteristics of the 
compound that act by limiting or favoring the rate of dispersion for electroactive species 
in the reaction medium [16, 17]. Therefore, when a compound has its mass-transfer 
controlled by diffusion and this is the limiting step of the reaction on a working electrode, 
the slope of the calibration curve (peak currents vs different concentrations) is connected 
to its the diffusion coefficient. Thus, besides the use of calibration curves for compound 
quantification, the value of the slope between the faradaic signal and the concentration is 
theoretically singular and even distinguishable, allowing complementary identification of 
electroactive molecules [16, 17].  
In the light of the insights, the present work aims to combine the slope obtained 
from DPV calibration graphs, as an alternative tool of identification. Besides this approach 
will also provide the identification of different molecules such as: Paracetamol (PAR), 
Promethazine (PMZ), Diclofenac (DIC), Piroxicam (PRX), Indomethacin (IND) and 
Cyclobenzaprine (CBP) in pharmaceutical assays by using the slope of the curve that 
relates the square root with the sweep speed and current. The choice of Graphite Pencil 
Electrodes have as the foundation on good performance of this material in other studies, 
highlighting its ease of cleaning, access and low cost. Moreover, the target samples were 
also identified by Raman spectroscopy, in order, to establish eventual comparisons. 
 
 
Material and methods 
 
 
Materials and samples 
2.0 mm HB graphite rod (Faber-Castel) was purchased from local stationery. 
Paracetamol (PAR), Promethazine (PMZ), Diclofenac (DIC), Piroxicam (PRX), 
Indomethacin (IND) and Cyclobenzaprine (CBP) standards (Figure 1) were purchased 
from Sigma Aldrich (Saint Louis, USA).  
 
 
Figure 1. Chemical structures of PMZ, DIC, PRX, PAR, IND and CBP standards. 
 
The tablets of each selected drug (Table 1) were purchased in a local pharmacy. 
 
TABLE I.  Selected target samples description. 
Drug Dosage 
Form 
Declared 
content 
(mg) 
Average weight 
(mg) 
Therapeutic 
Category 
PAR Tablet 750 836 mild analgesic 
DIC Tablet 50 192 NSAID* 
PMZ Tablet 25 172 antihistaminic 
IND Tablet 25 239 NSAID* 
PRX Capsule 20 309 NSAID* 
CBP Tablet 10 161 muscle relaxant 
*Non-steroidal anti-inflammatory drug 
Ten tablets or capsules of each target sample were used to estimate the average 
weight (table 1) and then powdered in a mortar. A suitable amount of each sample was 
solubilized and centrifuged at 400 rpm for 5 minutes, in order to prepare equivalent molar 
stock solutions. The identification assays were performed with 32 µmol.L-1 assay solutions. 
The calibration graphs were constructed by using proper aliquots, respecting the linear 
response of each target sample. All chemicals and solvents were of analytical grade, used 
without further purification. Stock solutions were prepared prior to the experiments and 
were diluted in Milli-Q water (conductivity ≤ 0.1μScm-1) (Millipore S.A. S., Molsheim, 
France).  
 
 
 
 
2.2 PGE preparation 
 
The PGE was inserted in a plastic casing, exposing only the circular 2.0 mm 
graphite area. The plastic casing was used with the purpose of restricting the contact of the 
graphite with the solution. After each assay, the pencil was polished in a Jet401 Norton 47F 
1200 sandpaper and it was further smoothed in writing paper. The polishing was achieved by 
drawing 10 full circles of 0.5 cm, whereas smoothing was executed by doing 3 circles of the 
same size. 
 
Electrochemical assays 
The voltammetric measurements were performed in a potentiostat/galvanostat 
µAutolab III ® integrated with GPES 4.9 ® software, Eco-Chemie, Utrecht, The 
Netherlands. Measurements were carried out using a three-electrode system in a 2 mL one-
compartment electrochemical cell (Cypress System Inc., USA). PGE (d = 2.0 mm) were 
the working electrodes, Pt wire the counter electrode and the Ag/AgCl (3 mol.L-1 KCl) 
reference electrode. The PGE was inserted in a plastic casing, exposing only the circular 
2.0 mm graphite area. The plastic casing was used with the purpose of restricting the 
contact of the graphite with the solution. A carbon paste electrode (CPE) was prepared as 
a piston-driven holder containing 70% of graphite powder and 30% of Nujol® (d = 2.0 
mm) was also used just for punctual comparisons of robustness. The surface of the carbon 
paste electrode (CPE) was mechanically renewed after each experiment by extruding 
approximately 0.5 mm of carbon paste out of the electrode holder and smoothing it with 
filter paper. This procedure ensured very reproducible experimental results.  
 
The pH measurements were carried out with a Quimis pH-meter Q400AS 
(Quimis®, São Paulo, Brazil) with an Ingold combined glass electrode. All experiments 
were done at room temperature (25 ± 1 ºC) and microvolumes were measured using EP-10 
and EP-100 Plus Motorized Microliter Pippettes (Rainin Instrument Co. Inc., Woburn, 
USA). 
 
The experimental conditions for differential pulse (DP) voltammetry were: pulse 
amplitude 50 mV, pulse width 70 ms and scan rate 10 mV s-1. For cyclic voltammetry (CV), 
the scan range from 0 to 1.2 V at rates of 25, 50, 100, 250 and 500  mV s-1 were used. Prior 
to the DPV assays of each sample, CV scans were recorded in blank buffer solution until a 
steady state baseline was obtained. This procedure ensured reproducible experimental 
results. All experiments were performed in triplicate with pH 7.0 0.1M phosphate buffer 
as electrolyte.  
 
Acquisition and Presentation of Voltammetric Data 
All the voltammograms presented were background-subtracted and baseline-
corrected using the moving average application with a step window of 5 mV included in 
GPES version 4.9 software. This mathematical treatment improves the visualisation and 
identification of peaks over the baseline without introducing any artefact. Though the peak 
intensity can vary slightly (<10%), in comparison to untreated curves, this variation occurs 
equally for all samples, when the same procedure is applied, being therefore, neglectable. 
The values for peak current presented in all plots were determined from the original 
untreated voltammograms after subtraction of the baseline. All data was analyzed and 
treated using the statistical software Origin 9®.  
 
Raman assays 
 
A Mira M-1 portable Raman spectrometer (Metrohm, Herisau, Switzerland) 
equipped with a 785 nm source and a maximum laser output power of 75 mW was 
employed to obtain the spectra. The spectra were recorded in a spectral range of 800 to 
1800 cm−1, with average spectral resolution of 12 and 14 cm−1. The measurement was 
carried out by using a glass vial holder (12 x 32 mm) completely filled with c.a. 1g of each 
sample.  
 
Statistical analysis 
 
Statistical analysis was performed using Origin 9®. Correlations among slopes 
obtained from calibration graphs with the standards and dosage forms were made. Both 
datasets of standard and dosage forms were analyzed individually. A third dataset 
(standards and dosage forms) was created to established correlation between their 
parameters. ANOVA and Tukey’s test were perfomed for all three datasets. The 
significance level (α) considered was 0.05. 
 
 
Results and discussion 
 
 
Raman spectroscopy and differential pulse voltammetry were performed in order 
to acquire identification data for the following drug standards and their respective tablets: 
IND, PRC, PRX, PMZ and DIC.  
 
The DPV assays were performed using equal experimental conditions, namely 
standards of each raw materials, as well as, the powdered tablets, were diluted in order to 
get 32 µmol.L-1 solution, whereas, the electrolyte was 0.1M phosphate buffer pH 7.00. In 
turn, the surface area of the GPE was cleaned and polished prior each measurement 
achieving a rapid and effective analysis. The DPVs of the evaluated drug standards and 
tablets are shown in Figure 2.  
 
 
Figure 2. DPVs obtained for 32 µmol.L-1 solutions of IND (A), PAR (B), PRX (C), PMZ 
(D), DIC (E) and CBP (F) for standards (– – –), tablets (––––) and 0.1M phosphate buffer, 
pH 7.0 (…...). All in 0.1M phosphate buffer, pH 7.0 at PGE. Amplitude of 50 mV, scan 
rate of 10 mV/s, scan range from 0.2 to 0.9 V.  
 
The DPVs of the target samples herein studied, exhibited peak potentials, at  
Ep1a = 0.75 V for IND (Fig. 2A); Ep1a = 0.35 V for PAR (Fig. 2B); Ep1a = 0.55 V for PRX 
(Fig. 2C); Ep1a = 0.55 V for DIC (Fig. 2E), two anodic peak, 1a and 2a, at Ep1a = 0.52 V 
and Ep2a = 0.75 V for PMZ (Fig. 2D) and for CBP Ep1a = 0.65 V and Ep2a = 0.9 V (Fig. 2E). 
 
The voltammetric profile presents some particular distinguishable features, that 
could allow the tentative identification. For instance, the main electrochemical parameters, 
peak potential, Ep, and peak current, Ip, as well as, the number of peaks observed in a 
particular voltammogram are useful identification patterns. In this sense, except, for DIC 
(Figure 2C) and PRX (Figure 2E), all target samples exhibited distinguishable differences 
(Figures 2). 
 
The Raman spectrum of each powdered sample of standards and tablets are shown 
in Figure 3.  
 
 
Figure 3. Raman spectrum of the standards (- - -) and tablets (  ) of IND (A), PAR (B), 
PRX (C), PMZ (D), DIC (E) and CBP (F).   
 
The Raman spectrum of each drug showed a unique profile, proving that this 
technique a viable option [15]. Nevertheless, the Raman spectra of pure standard and its 
representative tablet shown remarkable differences, especially for higher potency drugs, in 
which the proportion between active component and excipients is lower. Indeed, the light 
dispersion of the starch, a common excipient diluent in tablets, occurs between 800-1800 
cm-1, and the occlusion of the drugs related peaks is more significant, accordingly to the 
ratio among declared content and average weight. For instance, the ratio of PMZ, DIC, 
IND, PRX, and CBP were lower than 15%, producing huge spectral differences. In turn, 
for PAR (750 mg/ 835.9 mg), the unique case in which the direct identification was 
feasible, this ratio was almost of 90%. Therefore, the direct identification of a particular 
drug in dosage forms, in which the interference of excipients is relevant, is possible only 
with Raman coupled to chemometric tools [14,15, 18,19].     
 
In turn, if the redox behavior of selected target drugs are distinct, since the 
excipients are mostly non-electroactive species, the prompt identification of drugs may be 
feasible by DPV even if directly applied to their related dosage forms (Figure 2A, 2B and 
2C or 2D, 2E and 2F). Yet for drugs of similar voltammetric profile (Figure 2C and 2E), 
this approach would be useful as a complementary identification tool, possessing from non-
negative to indicative status [20].  
 
Since the electroactivity of each specie is centered in different functional groups or 
molecular sites, the redox process occur in distinguishable ways (Scheme 1S, 
Supplementary material). Therefore, the extensive electrochemical characterization afford 
useful insights. For better exploitation in the application of DPV, it is possible that the 
drugs could be differentiated by the variation of the analysis medium, or by the application 
of the technique. Figure 4I shows the behavior of successive scans for PRX drugs (Figure 
4IA) and DIC (Figure 4IB). In this study the PRX presented an adsorptive profile 
differently from the DIC, a parameter that may be useful to differentiate drugs, previously 
indistinguishable, with the use of the technique.  While the PRX (Figure 4IA) adsorbs 
strongly on the surface of the electrode, the DIC (Figure 4IB) generates new compounds 
that are oxidized in a second successive scan. The Figure 4II shows the effect of pH 5.00 
and 7.00 to facilitate the differentiation between PMZ (Figure 4IIA) and CBP (Figure 
4IIB), since only PMZ exhibits two oxidative processes at pH 5.00. Thus, pH variation can 
be used to identify compounds according to the study design. 
 
 
Figure 4. I) DP voltammograms obtained for 32 µmol.L-1 solutions of PRX (A) and DIC 
(B) in pH 7.0 0.1 M PBS, first scan (), second scan (– – –), and 0.1M phosphate buffer, 
pH 7.0 (…...).  II) DP voltammograms obtained for 32 µmol.L-1 solutions of PMZ (A) and 
CBP (B) in pH 7.0 0.1 M PBS () and in pH 5.0 0.1 M PBS (– – –).   
 
Concerning the experimental conditions, some instrumental parameters, i.e. scan 
range, scan direction and scan rate may have particular impact on the voltammetric profile 
of each compound. In this context, CV scans were performed at different scan rate for PAR, 
PMZ, CBP, PRX and DIC. The slopes obtained from Ipa vs. square root of scan rate (ν1/2 ) 
plots presented distinguishable values (Figure 5A).  
 
In the same way, DPV assays at PGE were also carried on the quantification of each 
drug sample, whereas the corresponding slope obtained from each calibration curves was 
explored with identification purposes. The resulting graphs (Figure 5B), in which the clear 
differences endorses the identification process.  
 
The slope was verified on carbon paste electrodes, with the sole purpose of 
verifying the behavior on distal electrodes. For this, three drugs with closer slopes were 
chosen when evaluated in PGE (Figure 5C, 5D, 5E).   
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Figure 5. PAR (►), PMZ (●), DIC (■), PRX (▲), IND (♦), CBP () drug standards, and 
related commercial tablets (blank signs) at PGE in pH 7.0 0.1 M PBS. A) Ip1a vs ν1/2 plots 
obtained at different scan rates (10, 25, 50, 100 and 250 mV.s-1). B) Calibration curves 
obtained from DPV assays. Assay obtained for three concentration levels at day two of: C) 
PAR, D) PMZ and E) DIC at the same PGE and in the same experimental conditions 
described in Figure 4B. The grey (- - -) line show the same experiment at CPE. 
The distinct slopes observed for different drugs is in agreement with the crucial role 
of structural and chemical properties on the electrode kinetics, in which diffusional and 
electronic limiting factors play different role [16,17].  
In order to testify the feasibility of the current proposal, the same procedure was 
applied for solid dosage forms formulated with the related drugs (Table 1). 
When performed at same experimental conditions, the voltammograms and the 
resulting slopes exhibited identical profiles (Figure 4A and 4B, black and blank signs) for 
assay solutions prepared from pure standards and from dosage forms (drug plus excipients). 
Therefore, the differences observed for both slope profiles, evidences that the current 
intensity is not only consequence of concentration loading of electroactive species, as 
stated by Faraday Law, but also related to diffusional and kinetic parameters.   
The insights for tentative identification of different molecules is based on the 
equations from Randles-Sevcik [21], which for irreversible electrochemical processes with 
one or multiple electrons can be applied according to equations 1 and 2, respectively: 
0.5 µA
 
𝐼𝐼𝐼𝐼 = 2.99 𝑥𝑥 105𝑛𝑛AC (𝛽𝛽𝑛𝑛D𝑣𝑣)1/2                                                                                      (1) 
 
𝐼𝐼𝑝𝑝 = 2.99 𝑥𝑥 105  (𝑛𝑛′ + 𝛽𝛽𝑛𝑛′+ 1)1/2𝑛𝑛 𝐷𝐷1/2 𝐶𝐶𝑜𝑜 𝐴𝐴𝑣𝑣1/2                                                     (2) 
 
Where, Ip is the peak current in A, n’ is the sum of the number of electrons involved 
before the electron transfer slow step and  βn’+1 and the transfer coefficient of this rate 
determining, n is the total number of electrons involved, D is the diffusion coefficient of 
the electroactive specie in cm2 s-1, A is the geometric area of working electrode in cm2, 
C0 is the concentration of the electroactive species in mol cm-3, and v is the potential scan 
rate in V s-1. 
 
 
As can been seen by this equation it is possible to keep constant all conditions and 
to change only the scan rate. In this context, first the slope for IP vs scan rate is verified 
for a standard of the analyte in the same conditions of the sample and after that a new 
study is made with this slope for pharmaceutical samples containing the respective 
analyte. In addition, as each electroactive molecule on working electrode can have 
different D and n, and βn’+1, the slope of this curve should be different for each analyte 
and can be used for a possible identification in pharmaceutical samples such as have been 
shown in Table 2. 
 
Furthermore, using the same equation above and keeping some constant 
conditions, as same working electrode and scan rate, the sensitivity of an electroactive 
molecule for electrochemical detection depend on of the same terms D and n, and βn’+1 
of analyte. Thereby, the slope of calibration curve (Ip vs C) could also be used for a 
possible identification of an analyte (Table 2). 
 
This evaluation is possible because all of them the value of n for their first oxidation 
processes have reported to be 2 [22-28]. In this context, using equation 2 for all studied 
molecules only two parameters D and B of these analytes can be used to explain the 
difference in slopes. In general, according to values of D that it have been reported for each 
molecules when D is higher for an analyte higher the slopes for calibration curve 
(sensitivity) and for scan rate study are. The D for each molecule is related with its size 
and charge as well as with used medium (electrolyte and pH). On the other hand, the 
transfer coefficient of this rate determining (βn’+1) needs also be considered. This term is 
related to an activation overpotential that each electroactive molecule has on a working 
electrode surface. This happens because each electroactive analyte has different redox 
groups and these can offer an electrochemical process easier or harder depending on used 
working electrode as well as of electrochemical conditions [24,26,27,31,32].  
 
The electrochemical behavior with its respective proposed mechanism for the 
majority studied molecules has been reported and the number of involved electrons and 
protons as well as the electroactive group for each molecule can be seen in new table 
added in the supplementary information (Scheme S1). In these new references added can 
be seen the suggestion of the redox mechanism for each studied molecule, but using 
different working electrodes.  
 
Thus, it can be inferred that both slope approaches (Figure 4A and B) provide 
suitable selectivity to allow the direct identification of raw material samples that presents 
distinguishable redox behavior (Scheme, S1),  as well as, of drugs present in dosage forms, 
that are featured as matrices of low complexity (Table 2).  
 
TABLE 2. Slopes obtained from Ipa vs. ν1/2 plot and calibration graph. 
 
Drug 
 
Ep1a/2a 
Ipa vs. ν1/2 slopes** Calibration curve slopes* 
S DF S DF 
PAR 0.35 0.39±2.2 0.39±2.4 0.19 ±2.1 0.19±3.1 
PMZ 0.52 / 0.75 1.25±3.7 1.25±5.1 0.10±2.8 0.10±4.0 
DIC 0.55 0.24±4.9 0.24±5.2 0.06±5.5 0.06±3.9 
IND 0.75 1.24±4.9 1.24±5.1 0.002±4.2 0.002±5.3 
PRX 0.55 0.40±3.3 0.40±3.4 0.02±6.1 0.02±4.6 
CBP 0.65 / 0.90 0.77±7.7 0.77±8.3 0.03±6.0 0.03±4.8 
Legend: S (standard) and DF (dosage form) assay solutions.  
* µA (mmol.L) -1; **(mV.s-1)1/2, RSD values < 8% (n =3). 
 
In order to validate the difference between the slopes of each drug calculated with 
the calibration curves and to confirm that these parameters do not deviate between standard 
and dosage forms, statistical analysis ANOVA and Tukey’s test were performed, with 0.05 
significance level (α = 0.05) (Figure 6).  
  
Figure 6. Graphical box charts of slope value ranges of the standards (A), dosage forms 
(B) calculated with the calibration graphs, between both of them (C) and statistical analysis 
of A: standard, B:dosage form and C:standard-dosage form datasets (S, DF and S-DF 
respectively) with ANOVA and Tukey’s test (D) (Null Hypothesis: The means of all levels 
are equal; Alternative Hypothesis: The means of one or more levels are different). 
 
The calculated P-values for the slope values of the standards (Figure 6) and dosage 
forms (Figure 6B) were smaller than the significance level (Figure 6D) (α > P), thus, each 
slope value for each individual drug is sufficiently different to be regarded as a unique 
parameter for identification. The Tukey’s test was performed for each drug combination 
(PAR, PMZ, DIC, IND, PRX and CBP) in pairs. The P-value was also smaller than the 
significance level (α > P), thus, indicating that the difference of the slopes are significant 
between each paired drug. In the ANOVA analysis of the dataset created to compare 
standards and dosage forms (Figure 6C), as expected, the null hypothesis was validated 
and the same conclusion was achieved in the Tukey’s test (α < P). This indicates that the 
slopes between standard and dosage form do not differ and are both equally viable to be 
used for the identification of the drugs investigated in this study.  
 
The presence of other electroactive species in samples can disturb the slopes and 
this is a limitation of the proposed method when a pharmaceutical formulation presents 
more than one drug. However, in this case, a simultaneous analysis of these drugs can be 
investigated for each specific pharmaceutical sample and if the potential peak for each 
analyte present a good resolution, it can also be possible to use slopes from Ip vs scan rate 
or Ip vs C for a possible identification.  It worth also mention that the changing in the slopes 
provide by presence of other electroactive species in the pharmaceutical sample could be 
used to identify a possible interferent in this sample.  
 
The presence of other electroactive species in samples can disturb the slopes and 
this is a limitation of the proposed method when a pharmaceutical formulation presents 
more than one drug. However, in this case, a simultaneous analysis of these drugs can be 
investigated for each specific pharmaceutical sample and if the potential peak for each 
analyte present a good resolution, it can also be possible to use slopes from Ip vs scan rate 
or Ip vs C for a possible identification.  It worth also mention that the changing in the slopes 
provide by presence of other electroactive species in the pharmaceutical sample could be 
used to identify a possible interferent in this sample.       
 
Finally, the reproducibility of the use of slope approach was tested in different days, 
with preparation of new solutions obeying all the standards of analysis being found RSD 
values approximate 8%. In fact, different carbon electrodes would present different 
electrode kinetics. In fact, the slopes obtained at CPE presented differences visual and 
statically significant of PGE (Figure 5C, 5D, 5E). Nevertheless, any electrode materials 
presenting the same electroactive surface area and chemical properties can be applied.  
  
Finally, owing to the use of PGE to quantify the drug samples, the recoveries ranged 
from 97 to 103 5%, whereas the RSD was lower than 5% (n = 3). The linear regressions of 
all target samples are presented in Table 3. 
TABLE 3. Analytical parameters of quantitative assay  
Drug Linear Regression 
Equation (Standards) 
Linear 
correlation (R) 
Linear range 
(µmol.L-1) 
LOD 
(µmol.L-1) 
Recovery 
(%)* 
PAR y = -4.4 .10-7 + 0.19x 0.997 4.9 - 38 2.50 97.6 
PMZ y = -2.3 .10-7 + 0.10x 0.986 4.9 - 38 4.40 97.1 
DIC y = -2.3 .10--7 + 0.06x 0.985 9.9 - 56 6.72 98.0 
IND y = -7.5.10--9 + 0.002x 0.996 15 - 107 18.35 98.4 
PRX y = 1.1 .10-6 + 0.02x 0.994 2.9 - 160 39.81 103.6 
CBP y = -2.1.10-7 + 0.03x 0.991 18 - 60 9.5 98.1 
*related to the labeled value 
 
Thus, tilt profiles were statistically similar when compared to results from the same 
drug, with significant matching between patterns and samples. When comparing drugs 
different from each other, the slopes did not match. These results show that such a 
parameter may be a complementary tool for the identification of drugs in samples. These 
results are possibly due to the unique characteristics of the molecules that interfere both in 
the reaction kinetics and in the diffusional profile in the evaluated medium. Electrodes with 
distinct characteristics change the kinetic profile of the reactions.  
 
Furthermore, the identification process in quality control must be assessed by three 
or more simple methods of low level of confidence, the voltammetric approach upsurges 
as a potential alternative (Table 2, supplementary material). 
 
 
Conclusions 
 
 
The methodology for compounds identification by using slope of the calibration 
curve (peak currents vs different concentrations) obtained by DPV, and the slope of the 
study of the speed of sweep (slope of square root of the speed and current, served as 
complementary tool to identify drugs. The low cost PGEs showed to be useful for 
quantitative and qualitative analysis of drug samples. The DPV profile for the target 
samples, herein investigated showed even more distinguishable features than the 
conventional Raman spectra, thus the proposed methodology is very promising in order to 
accurately identify pharmaceutical compounds in commercial samples. 
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